- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06077825
Effects of Lower Limbs Symmetrical Loading on Risk of Fall
Does Symmetrical Lower Limb Loads Distribution Effects Balance and Risk of Fall After Total Hip Arthroplasty?
Objective: To assess the impact of total hip arthroplasty (THA) on functional outcomes and fall risk in patients with hip osteoarthritis. The objective was to investigate the effectiveness of physical therapy in postoperative rehabilitation and identify fall risk factors to guide fall prevention strategies after THA.
Methods: A non-randomized, interventional clinical trial was conducted with 30 patients scheduled for THA. Functional outcomes were evaluated using the Harris Hip Score (HHS), 40-meter fast-paced walk test (40mFPWT), 30-Second Chair Test, and Western Ontario McMaster Universities Osteoarthritis Index (WOMAC). Balance and fall risk were assessed using the Single-Leg Standing Test and a posturography device (TETRAX). The Nottingham Health Profile (NHP) was used to measure subjective health status and quality of life. Assessments were performed preoperatively, at 6 weeks postoperatively, and at 3 months postoperatively.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical and radiographic evidence of unilateral hip osteoarthritis
- Volunteering to participate in the study
Exclusion Criteria:
- History of neurologic disorders affecting postural control (e.g., Parkinson disease)
- Have other problems that affect balance, such as vertigo
- Undergoing revision hip surgery
- Osteoarthritis in the other lower extremity joints
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental group
30 patients who underwent total hip arthroplasty surgery took part in the experimental group.
|
30 patients took postoperative rehabilitation after total hip arthroplasty surgery, 3 times a week, for 6 weeks.
They took conventional rehabilitation (hip range of motion exercises, progressive strengthening exercises for hip and knee muscles, balance and proprioceptive exercises and gait training).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Harris Hip Score (HHS)
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
min-max (0-100) Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.
|
preoperative, postoperative 6 weeks and 3 months
|
|
40-meter fast-paced walk test
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
preoperative, postoperative 6 weeks and 3 months
|
|
|
30-Second Chair Test
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
preoperative, postoperative 6 weeks and 3 months
|
|
|
Western Ontario McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
It is a self-administered questionnaire consisting of 24 items divided into 3 subscales: Pain, Stiffness, Physical Function.
Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
|
preoperative, postoperative 6 weeks and 3 months
|
|
Static balance and fall risk
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
It was assessed with Posturography device (TETRAX)
|
preoperative, postoperative 6 weeks and 3 months
|
|
Single-Leg Standing Test
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
preoperative, postoperative 6 weeks and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Nottingham Health Profile (NHP)
Time Frame: preoperative, postoperative 6 weeks and 3 months
|
The NHP is composed of 38 items divided into six domains:
|
preoperative, postoperative 6 weeks and 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Selvi Yüce, PhD(c), Acibadem Maslak Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AcibademHospital
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.